Loading...
Symbols:
Loading...
Symbols:
Breaking News | Real-time commentary on the market, with links to key sources.
Thursday, August 28 2008
- 12:38 PM Amgen (AMGN) will no longer offer rebates on its anemia drug Aranesp, after critics argued that the rebates contributed to overprescription. Amgen said it will instead offer bigger discounts at the time of purchase.
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »